Back to Search Start Over

Updates on HTLV-1 Uveitis.

Authors :
Kamoi K
Watanabe T
Uchimaru K
Okayama A
Kato S
Kawamata T
Kurozumi-Karube H
Horiguchi N
Zong Y
Yamano Y
Hamaguchi I
Nannya Y
Tojo A
Ohno-Matsui K
Source :
Viruses [Viruses] 2022 Apr 12; Vol. 14 (4). Date of Electronic Publication: 2022 Apr 12.
Publication Year :
2022

Abstract

HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM). Recent studies have addressed several long-standing uncertainties about HU. HTLV-1-related diseases are known to be caused mainly through vertical transmission (mother-to-child transmission), but emerging HTLV-1 infection by horizontal transmission (such as sexual transmission) has become a major problem in metropolitan areas, such as Tokyo, Japan. Investigation in Tokyo showed that horizontal transmission of HTLV-1 was responsible for HU with severe and persistent ocular inflammation. The development of ATL and HAM is known to be related to a high provirus load and hence involves a long latency period. On the other hand, factors contributing to the development of HU are poorly understood. Recent investigations revealed that severe HU occurs against a background of Graves' disease despite a low provirus load and short latency period. This review highlights the recent knowledge on HU and provides an update on the topic of HU in consideration of a recent nationwide survey.

Details

Language :
English
ISSN :
1999-4915
Volume :
14
Issue :
4
Database :
MEDLINE
Journal :
Viruses
Publication Type :
Academic Journal
Accession number :
35458524
Full Text :
https://doi.org/10.3390/v14040794